Obstructive sleep apnea and hypertension

Journal of Clinical Hypertension

Volumn 10, Issue 7, 2008, Pages 549-555

  Okcay, Aynur ^a   Somers, Virend K ^a   Caples, Sean M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NITRATE; NITRIC OXIDE; NITRITE;

ACTIMETRY; BLOOD PRESSURE REGULATION; BREATHING MECHANICS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEMORECEPTOR REFLEX; DAYTIME SOMNOLENCE; DEOXYGENATION; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; HYPOXEMIA; LEUKOCYTE ADHERENCE; OBESITY; OXYGEN THERAPY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SELF REPORT; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP PATTERN; UPREGULATION; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; PATHOPHYSIOLOGY; RISK FACTOR;

CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPERTENSION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 54449098088     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07811.x     Document Type: Review

References (63)

1. Staessen J, Bulpitt CJ, O'Brien E, et al. The diurnal blood pressure profile. A population study. Am J Hypertens. 1992;5(6, pt 1):386-392.
2. Staessen JA, Fagard RH, Lijnen PJ, et al. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991;67(8):723-727.
3. Hornyak M, Cejnar M, Elam M, et al. Sympathetic muscle nerve activity during sleep in man. Brain. 1991;114(pt 3):1281-1295.
4. Somers VK, Dyken ME, Mark AL, et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303-307.
5. Verrier RL, Muller JE, Hobson JA. Sleep, dreams, and sudden death: The case for sleep as an autonomic stress test for the heart. Cardiovasc Res. 1996;31(2):181-211.
6. Spiegel K, Tasali E, Penev P, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850.
7. Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272(3):205-211.
8. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206.
9. National Sleep Foundation. Sleep in America Poll. Washington, DC: National Sleep Foundation; 2002.
10. Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: Analyses of the NHANES I. Sleep. 2005;28(10):1289-1296.
11. Egan BM. Sleep and hypertension: Burning the candle at both ends really is hazardous to your health. Hypertension. 2006;47(5):816-817.
12. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: Analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833-839.
13. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: The Sleep Heart Health Study. Sleep. 2006;29(8):1009-1014.
14. van den Berg JF, Tulen JH, Neven AK, et al. Sleep duration and hypertension are not associated in the elderly. Hypertension. 2007;50(3):585-589.
15. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2(8607):397.
16. Ingelsson E, Bjorklund-Bodegard K, Lind L, et al. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006;295(24):2859-2866.
17. Timio M, Venanzi S, Lolli S, et al. "Non-dipper"hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study. Clin Nephrol. 1995;43(6):382-387.
18. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271-2277.
19. Carrington MJ, Barbieri R, Colrain IM, et al. Changes in cardiovascular function during the sleep onset period in young adults. J Appl Physiol. 2005;98(2):468-476.
20. Engleman HM, Gough K, Martin SE, et al. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/ hypopnea syndrome: Effects in "non-dippers". Sleep. 1996;19(5):378-381.
21. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239.
22. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002;162(16):1867-1872.
23. Sonne-Holm S, Sorensen TI, Jensen G, et al. Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men. BMJ. 1989;299(6702):767-770.
24. Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: Results of a meta-analysis. Arch Intern Med. 2003;163(5):565-571.
25. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial. Lancet. 1999;353(9170):2100-2105.
26. Vallbo AB, Hagbarth KE, Torebjörk HE, et al. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919-957.
27. Somers V, Mark A, Abboud F. Interaction of baroreceptor and chemoreceptor control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87:1953-1957.
28. Somers VK, Mark AL, Zavala DC, et al. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol. 1989;67(5):2095-2100.
29. Smith ML, Niedermaier ON, Hardy SM, et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst. 1996;56(3):184-190.
30. Narkiewicz K, van de Borne PJH, Pesek CA, et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 1999;99(9):1183-1189.
31. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897-1904.
32. Heistad DD, Abboud FM, Mark AL, et al. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest. 1974;53(5):1226-1236.
33. Hedner JA, Wilcox I, Laks L, et al. A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis. 1992;146(5, pt 1):1240-1245.
34. Blasi A, Jo J, Valladares E, et al. Cardiovascular variability after arousal from sleep: Time-varying spectral analysis. J Appl Physiol. 2003;95(4):1394-1404.
35. Narkiewicz K, Van De Borne PJH, Montano N, et al. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation. 1998;97(10):943-945.
36. Narkiewicz K, Montano N, Cogliati C, et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998;98(11):1071-1077.
37. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The framingham heart study. Circulation. 1996;94(11):2850-2855.
38. Kato M, Roberts-Thomson P, Phillips B. Impairment of endothelium-sependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102:2607-2610.
39. Carlson JT, Rângemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens. 1996;14(5):577-584.
40. Kraiczi H, Hedner J, Peker Y, et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol. 2000;89(2):493-498.
41. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17(1):61-66.
42. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165(5):677-682.
43. IP MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670-676.
44. Punjabi NM, Ahmed MM, Polotsky VY, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol. 2003;136(2-3):167-178.
45. Harsch IA, Schahin SP, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169(2):156-162.
46. Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep. 2004;27(6):1053-1055.
47. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165(7):934-939.
48. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162(2):566-570.
49. Von Kanel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest. 2003;124(5):1956-1967.
50. Ip MSM, Lam B, Chan L, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-2171.
51. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384.
52. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239.
53. Pankow W, Lies A, Lohmann FW. Sleep-disordered breathing and hypertension. N Engl J Med. 2000;343(13):966-967.
54. Ali NJ, Davies RJ, Fleetham JA, et al. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest. 1992;101(6):1526-1532.
55. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: A placebo trial. Hypertension. 2000;35(1):144-147.
56. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised parallel trial. Lancet. 2002;359(9302):204-210.
57. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107(1):68-73.
58. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med. 2001;134(11):1015-1023.
59. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J. 2006;27(6):1229-1235.
60. Hui DS, To KW, Ko FW, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax. 2006;61(12):1083-1090.
61. Norman D, Loredo Js, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension. 2006;47(5):840-845.
62. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: Evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757-764.
63. Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.